Non-fibrillar Amyloidogenic Protein Assemblies - Common Cytotoxins Underlying Degenerative Diseases (eBook)
VIII, 568 Seiten
Springer Netherland (Verlag)
978-94-007-2774-8 (ISBN)
Amyloid-forming proteins are implicated in over 30 human diseases. The proteins involved in each disease have unrelated sequences and dissimilar native structures, but they all undergo conformational alterations to form fibrillar polymers. The fibrillar assemblies accumulate progressively into disease-specific lesions in vivo. Substantial evidence suggests these lesions are the end state of aberrant protein folding whereas the actual disease-causing culprits likely are soluble, non-fibrillar assemblies preceding the aggregates. The non-fibrillar protein assemblies range from small, low-order oligomers to spherical, annular, and protofibrillar species. Oligomeric species are believed to mediate various pathogenic mechanisms that lead to cellular dysfunction, cytotoxicity, and cell loss, eventuating in disease-specific degeneration and systemic morbidity. The particular pathologies thus are determined by the afflicted cell types, organs, systems, and the proteins involved. Evidence suggests that the oligomeric species may share structural features and possibly common mechanisms of action. In many cases, the structure-function interrelationships amongst the various protein assemblies described in vitro are still elusive. Deciphering these intricate structure-function correlations will help understanding a complex array of pathogenic mechanisms, some of which may be common across different diseases albeit affecting different cell types and systems.
Preface1. Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins; Farid Rahimi and Gal Bitan2. Pathologic Lesions in Alzheimer disease and Other Neurodegenerative Diseases—Cellular and Molecular Components; Harry V. Vinters, Spencer Tung, and Orestes E. Solis3. Preparation and Structural Characterization of Pre-fibrillar Assemblies of Amyloidogenic Proteins; Anat Frydman-Marom, Yaron Bram, and Ehud Gazit4. Biological Targeting and Activity of Pre-fibrillar Aβ Assemblies; Kyle C. Wilcox, Jason Pitt, Adriano Sebollela, Helen Martirosova, Pascale N. Lacor, and William L. Klein5. The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s disease; Kiran Bhaskar and Bruce T. Lamb6. Oligomers of α-Synuclein in the Pathogenesis of Parkinson’s Disease; Dong-Pyo Hong, Wenbo Zhou, Aaron Santner3, and Vladimir N. Uversky7. Cytotoxic Mechanisms of Islet Amyloid Polypeptide in the Pathogenesis of Type-2 Diabetes Mellitus (T2DM); Theri L. Degaki, Dahabada H. J. Lopes, and Mari C. Sogayar8. Protein Misfolding and Toxicity in Amyotrophic Lateral Sclerosis; Aaron Kerman and Avijit Chakrabartty9. Structural Studies of Prion Proteins and Prions; Giuseppe Legname, Gabriele Giachin, Federico Benetti10. Role of Prion Protein Oligomers in the Pathogenesis of Transmissible Spongiform Encephalopathies; Rodrigo Morales, Claudia A. Duran-Aniotz, and Claudio Soto11. When More Is Not Better: Expanded Polyglutamine Domains in Neurodegenerative Disease; Regina M. Murphy, Robert H. Walters, Matthew D. Tobelmann, and Joseph P. Bernacki12. Protein Misfolding and Toxicity in Dialysis-Related Amyloidosis; John P. Hodkinson, Alison E. Ashcroft, Sheena E. Radford13. Transthyretin Aggregation and Toxicity; Maria J. Saraiva, Isabel S. Cardoso14. Strategies for Inhibiting Protein Aggregation: Therapeutic Approaches to Protein-Aggregation Diseases; Jennifer D. Lanning and Stephen C. Meredith
Erscheint lt. Verlag | 11.1.2012 |
---|---|
Zusatzinfo | VIII, 568 p. |
Verlagsort | Dordrecht |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
Studium ► 2. Studienabschnitt (Klinik) ► Pathologie | |
Naturwissenschaften ► Biologie ► Biochemie | |
Technik | |
Schlagworte | Amyloidogenic proteins • Degenerative/neurodegenerative diseases • Mechanisms of disease • Non-fibrillar oligomeric assemblies • Protein-misfolding diseases • Protein Structure |
ISBN-10 | 94-007-2774-7 / 9400727747 |
ISBN-13 | 978-94-007-2774-8 / 9789400727748 |
Haben Sie eine Frage zum Produkt? |
![PDF](/img/icon_pdf_big.jpg)
Größe: 10,1 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich